[OSL] YoY Annual Result on 30-Jun-2020 [#FY]

Stock
[OSL] OncoSil Medical Limited
Announcement Date
29-Jun-2020
Financial Year
2020
Quarter
30-Jun-2020 [#FY]
Profit Trend
YoY- 50.25%
Quarter Report
OSL's Result
OSL's Financial Summary
View:
Show?
Annual Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 368 232 213 2,764 3,626 4,448 3,514 -31.33%
PBT -12,443 -11,558 -11,511 -7,025 -12,193 -12,980 -10,462 2.93%
Tax -1,100 -832 -1,077 -2,763 -3,626 -4,441 -3,446 -17.32%
NP -11,343 -10,727 -10,434 -4,262 -8,567 -8,540 -7,016 8.33%
Tax Rate - - - - - - - -
Total Cost 11,711 10,958 10,647 7,026 12,193 12,987 10,531 1.78%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin -3,085.02 -4,627.79 -4,896.76 -154.20 -236.25 -192.00 -199.64 57.78%
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
EPS -0.01 -0.01 -0.01 -0.00 -0.01 -0.01 -0.01 0.00%
EPS Diluted -0.01 -0.01 -0.01 -0.00 -0.01 -0.01 -0.01 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.